Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.71
-0.01 (-1.63%)
At close: Aug 15, 2025, 1:24 PM

Nautilus Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-70.78M -63.67M -57.92M -50.31M
Depreciation & Amortization
6.35M 5.71M 3.42M 2.84M
Stock-Based Compensation
12.7M 12.14M 10.38M 7.93M
Other Working Capital
-4.88M -3.61M -227K -1.28M
Other Non-Cash Items
-1.96M -2.66M -890K 320K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-5.46M -3.22M -788K -22K
Operating Cash Flow
-59.15M -51.71M -45.81M -39.24M
Capital Expenditures
-2.12M -2.44M -2.32M -2.27M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-86.28M -112.89M -186.59M -221.79M
Sales Maturities Of Investments
n/a 71.6M 163.18M 85.1M
Other Investing Acitivies
154.65M n/a n/a n/a
Investing Cash Flow
66.25M -43.73M -25.74M -138.96M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
524K 264K 232K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.14M 368K 562K 327.45M
Financial Cash Flow
1.14M 368K 562K 327.45M
Net Cash Flow
8.25M -95.08M -70.98M 149.24M
Free Cash Flow
-61.27M -54.15M -48.13M -41.51M